"Silencing" the expression of disease-causing genes using RNA interference (RNAi)
During gene expression, errors in DNA can result in faulty mRNA that cause or contribute to disease. Alnylam's RNAi therapeutics utilize specially designed small interfering RNA (siRNA) to target and degrade these mRNA, treating disease at source. Learn how.
How businesses turned health records from GE into a lucrative asset; EU health agency warns monkeypox could become endemic
Reviewed by Knowledge World
on
May 23, 2022
Rating: 5
No comments